Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens
PLOS One · 2025
DOI: 10.1371/journal.pone.0324003 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Chen Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, High-Throughput Nucleotide Sequencing, Bacterial Load, Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Fund for Scientific Innovation Strategy-Construction of High-level Academy of Agriculture Science.
Abstract (Originalsprache)
Introduction
The 2024 global tuberculosis report indicated that the epidemiological situation of tuberculosis remains concerning. Current tuberculosis detection methods have limitations, highlighting the urgent need to develop more convenient, effective, and widely utilized detection technologies in clinical settings to facilitate early diagnosis and treatment guidance for tuberculosis. Nanopore-based targeted next-generation sequencing (tNGS) offers advantages such as convenience, efficiency, and long-read sequencing, making it a commonly used method for mycobacteria identification.
Methods
This study compared the detection efficiency of tNGS with Xpert MTB/RIF, MTB culture, and AFB smear in sputum samples, BALF samples, and pathological tissue samples to evaluate the clinical applicability of tNGS in diagnosing tuberculosis and low bacterial load tuberculosis, including extrapulmonary and smear-negative cases.
Results
Among the four detection methods, tNGS demonstrated the highest efficiency, sensitivity, specificity, and AUC values, which are 93.4%, 94.7%, and 0.94, respectively. This method was particularly advantageous for detecting tuberculosis in patients with low bacterial loads, as evidenced by a significantly different positive detection rate in histopathological specimens compared to other methods (P < 0.001). Furthermore, tNGS achieved overall positive detection rates of 93.8% for smear-negative tuberculosis patients and 89.1% for culture-negative tuberculosis patients, both of which were significantly higher than those of other detection methods (P < 0.05). Additionally, tNGS could directly identify bacterial strains and detect mutations associated with drug resistance. In this study, the agreement rate between tNGS strain identification of NTM and the final diagnosis was 94.1%. Among the 21 identified mutation sites associated with rifampicin resistance, one (Pro454His) was located outside RRDR.
Conclusion
It is anticipated that tNGS will play a crucial clinical role in the early prevention and control of tuberculosis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Tuberculosis, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, China.
- Department of Tuberculosis, The Second Hospital of Nanjing, Nanjing, China.
ORCID-Profile: Yi Zeng
Förderung
- Special Fund for Scientific Innovation Strategy-Construction of High-level Academy of Agriculture Science
Zitieren
APA
Yang, C., Gao, W., Guo, Y., & Zeng, Y. (2025). Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens. PLOS One. https://doi.org/10.1371/journal.pone.0324003
Vancouver
Yang C, Gao W, Guo Y, Zeng Y. Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens. PLOS One. 2025. doi:10.1371/journal.pone.0324003
BibTeX
@article{Yang2025,
author = {Yang, Chen and Gao, Weiwei and Guo, Yicheng and Zeng, Yi},
title = {Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324003}
}
EUVIMED